ACTIVE

PHARMA & FLO

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

254,1 k €

-19.4% YoY

Gross margin

746,9 k €

-2.0% YoY

Equity

1,5 M €

+2.7% YoY

Workforce

7,6 ETP

-6.2% YoY

What does PHARMA & FLO do?

PHARMA & FLO is a Private limited company incorporated in 1996. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Namur. It employs on average 7,6 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0458.489.207

Incorporation

29/06/1996

Legal form

Private limited company

Registered office

Rue du Pont des Ardennes(JB) 20
5100 Namur · WallonieSee on map

Contributed capital

20 625,00 €

Latest accounts

31/12/2025

Average workforce

7,6 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	746,9 k €	-2.0%	762,1 k €	-1.8%	776,3 k €	+3.0%	753,5 k €	+13.2%	665,6 k €	+5.0%	634 k €	+3.0%	615,6 k €	+0.7%	611,2 k €	-2.4%	626,5 k €	-12.8%	718,6 k €	+5.0%	684,5 k €	+3.8%	659,3 k €	+2.6%	642,5 k €	+3.6%	620,2 k €	-2.4%	635,6 k €	+9.3%	581,6 k €	+2.3%	568,6 k €	+9.7%	518,4 k €	+861%	54 k €	-13.3%	62,3 k €
EBITDA	244,3 k €	-21.3%	310,4 k €	+3.4%	300,2 k €	-3.2%	310,2 k €	+16.5%	266,3 k €	+4.7%	254,3 k €	+4.4%	243,7 k €	+4.2%	233,8 k €	-5.1%	246,4 k €	-29.2%	347,9 k €	+8.3%	321,3 k €	-3.7%	333,8 k €	+26.0%	264,9 k €	+2.3%	258,8 k €	-10.2%	288,1 k €	+14.1%	252,5 k €	-2.7%	259,6 k €	+24.6%	208,3 k €	+385995%	-54 €	-100%	18,9 k €
Operating result	238,3 k €	-21.8%	304,7 k €	+5.3%	289,2 k €	-2.6%	296,9 k €	+15.3%	257,4 k €	+9.8%	234,4 k €	+9.4%	214,4 k €	+3.3%	207,5 k €	+49.6%	138,7 k €	-42.2%	240,3 k €	+7.5%	223,4 k €	-5.4%	236,1 k €	+44.4%	163,4 k €	+2.9%	158,9 k €	-15.6%	188,2 k €	+19.6%	157,3 k €	-2.0%	160,5 k €	+47.6%	108,7 k €	+517%	-26,1 k €	-302%	-6,5 k €
Net result	254,1 k €	-19.4%	315,1 k €	+11.9%	281,6 k €	-3.0%	290,4 k €	+6.1%	273,7 k €	+25.9%	217,3 k €	-25.2%	290,4 k €	+152%	115,2 k €	+69.6%	67,9 k €	-47.7%	130 k €	+20.1%	108,2 k €	-27.8%	149,9 k €	+43.9%	104,1 k €	+9.3%	95,3 k €	-10.2%	106,2 k €	+35.1%	78,6 k €	-17.3%	95 k €	+29.2%	73,6 k €	+317%	-33,9 k €	-122%	-15,3 k €
Balance sheet
Equity	1,5 M €	+2.7%	1,5 M €	+2.1%	1,4 M €	+13.8%	1,2 M €	+22.0%	1 M €	+16.3%	879,2 k €	+15.4%	761,9 k €	+61.6%	471,5 k €	-25.8%	635,3 k €	+12.0%	567,3 k €	+29.7%	437,3 k €	+29.0%	339,1 k €	-32.7%	504,2 k €	+17.0%	431,1 k €	+28.4%	335,8 k €	+46.3%	229,6 k €	+52.1%	151 k €	+170%	55,9 k €	+417%	-17,6 k €	-208%	16,3 k €
Total assets	2,6 M €	-1.3%	2,6 M €	+8.4%	2,4 M €	+6.7%	2,3 M €	+2.3%	2,2 M €	+2.9%	2,1 M €	+1.1%	2,1 M €	+7.2%	2 M €	-5.3%	2,1 M €	+96.8%	1,1 M €	+3.4%	1 M €	-1.9%	1 M €	-21.9%	1,3 M €	+25.4%	1,1 M €	-4.7%	1,1 M €	-13.8%	1,3 M €	+1.8%	1,3 M €	-10.2%	1,4 M €	+176%	514,2 k €	+0.6%	511,1 k €
Cash	330,2 k €	-22.1%	423,6 k €	+77.9%	238,1 k €	-26.1%	322,4 k €	+5.9%	304,3 k €	+26.1%	241,4 k €	-13.6%	279,5 k €	-29.5%	396,5 k €	+44.0%	275,4 k €	-31.3%	400,7 k €	+15.5%	346,8 k €	+69.3%	204,8 k €	+1.3%	202,2 k €	+955%	19,2 k €	-74.6%	75,4 k €	-47.5%	143,6 k €	+392%	29,2 k €	-74.2%	113,1 k €	+696%	14,2 k €	-72.1%	50,9 k €
Debts	1,1 M €	-6.3%	1,2 M €	+17.6%	981,5 k €	-2.1%	1 M €	-14.4%	1,2 M €	-6.3%	1,2 M €	-6.8%	1,3 M €	-9.6%	1,5 M €	+2.9%	1,4 M €	+200%	479,5 k €	-16.6%	574,6 k €	-18.2%	702,2 k €	-15.5%	831 k €	+31.2%	633,6 k €	-18.9%	781,1 k €	-26.7%	1,1 M €	-4.1%	1,1 M €	-17.8%	1,4 M €	+159%	521,6 k €	+7.4%	485,7 k €
Other
Workforce	7,6 ETP	-6.2%	8,1 ETP	+6.6%	7,6 ETP	+24.6%	6,1 ETP	-10.3%	6,8 ETP	-99.9%	11 351,0 ETP	+157553%	7,2 ETP	-2.7%	7,4 ETP	+7.2%	6,9 ETP	-12.7%	7,9 ETP	+8.2%	7,3 ETP	-3.9%	7,6 ETP	-9.5%	8,4 ETP	+13.5%	7,4 ETP	+8.8%	6,8 ETP	+4.6%	6,5 ETP	-1.5%	6,6 ETP	+22.2%	5,4 ETP	+286%	1,4 ETP	+7.7%	1,3 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 3 ended

Active mandates

THIERRY DELAHAUT

Director

Active

Ended mandates

Jean-Paul ROBEIN

Associate

Ended

THIERRY DELAHAUT

Manager

Ended

Véronique DEFOURNY

Manager

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	28/08/2026	28/08/2025	26/08/2024	20/07/2023	07/07/2022	02/08/2021
General meeting	26/06/2026	27/06/2025	28/06/2024	30/06/2023	24/06/2022	25/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	26/06/2026	28/08/2026	French	PDF
Abridged model	31/12/2024	27/06/2025	28/08/2025	French	PDF
Abridged model	31/12/2023	28/06/2024	26/08/2024	French	PDF
Abridged model	31/12/2022	30/06/2023	20/07/2023	French	PDF
Abridged model	31/12/2021	24/06/2022	07/07/2022	French	PDF
Abridged model	31/12/2020	25/06/2021	02/08/2021	French	PDF
Abridged model	31/12/2019	26/06/2020	30/06/2020	French	PDF
Abridged model	31/12/2018	28/06/2019	03/07/2019	French	PDF
Abridged model	31/12/2017	29/06/2018	06/07/2018	French	PDF
Abridged model	31/12/2016	30/06/2017	04/07/2017	French	PDF
Abridged model	31/12/2015	24/06/2016	29/06/2016	French	PDF
Abridged model	31/12/2014	26/06/2015	09/07/2015	French	PDF
Abridged model	31/12/2013	27/06/2014	28/08/2014	French	PDF
Abridged model	31/12/2012	28/06/2013	10/07/2013	French	PDF
Abridged model	31/12/2011	29/06/2012	18/07/2012	French	PDF
Abridged model	31/12/2010	24/06/2011	01/07/2011	French	PDF
Abridged model	31/12/2009	25/06/2010	02/07/2010	French	PDF
Abridged model	31/12/2008	26/06/2009	24/08/2009	French	PDF
Abridged model	31/12/2007	27/06/2008	17/07/2008	French	PDF
Abridged model	31/12/2006	29/06/2007	05/07/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 3 ended

Active mandates

THIERRY DELAHAUT

Director

Active

Ended mandates

Jean-Paul ROBEIN

Associate

Ended

THIERRY DELAHAUT

Manager

Ended

Véronique DEFOURNY

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates26/02/2025
MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE
PDF
Capital / shares30/01/2018
CAPITAL, ACTIONS
PDF
Mandates04/02/2014
CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
PDF
Mandates19/05/2008
DENOMINATION - SIEGE SOCIAL
PDF
Mandates18/03/2008
DEMISSIONS, NOMINATIONS
PDF
Capital / shares23/12/2003
CAPITAL, ACTIONS - ASSEMBLEE GENERALE - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025254,1 k €↓
2024
Annual accounts 2024315,1 k €↑
2023
Annual accounts 2023281,6 k €↓
2022
Annual accounts 2022290,4 k €↑
2021
Annual accounts 2021273,7 k €↑
2020
Annual accounts 2020217,3 k €↓
2019
Annual accounts 2019290,4 k €↑
2018
Annual accounts 2018115,2 k €↑
2017
Annual accounts 201767,9 k €↓
2016
Annual accounts 2016130 k €↑
2015
Annual accounts 2015108,2 k €↓
2014
Annual accounts 2014149,9 k €↑
2013
Annual accounts 2013104,1 k €↑
2012
Annual accounts 201295,3 k €↓
2011
Annual accounts 2011106,2 k €↑
2010
Annual accounts 201078,6 k €↓
2009
Annual accounts 200995 k €↑
2008
Annual accounts 200873,6 k €↑
2007
Annual accounts 2007-33,9 k €↓
2006
Annual accounts 2006-15,3 k €
29/06/1996
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

PHARMA & FLO

Overview

What does PHARMA & FLO do?

Trend over 20 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline